Blog | RMEI Medical Education | Continuing Medical Education

FEATURED BLOG

Current and Emerging Anti-VEGF Therapy Dosing Regimens for nAMD and DME

Iqbal was only 32 years old when he had his first, and rather sudden, experience with diabetic eye disease. While at work, he experienced a sudden flash of light that left what he described as a fingerprint in the middle of his vision in one eye. Although it got better by the day, it limited everything he could do, from reading to driving.

Ophthalmology
Blog

RMEI MEDICAL EDUCATION BLOGS

Don’t Treat Your Patients with Prurigo Nodularis the Way this Dermatologist Did

Two years ago, TLC aired an episode about a young Black woman named Natalie who broke out in tears while describing a condition that mysteriously appeared all over her skin. She showed her arms and legs to the camera, displaying a series of evenly spaced, raised, pigmented nodules, and described an intense need to scratch them.

Dermatology
Blog

The Oncology Nursing Mistake That is Hurting Your Practice

Non-melanoma skin cancers (NMSC) are common. Fortunately, they tend to have excellent survival and cure rates, but some of the more locally advanced and metastatic forms do not.

Blog

What a Perfect NCFBE Patient Looks Like… And Why It’s a Problem

Woody was diagnosed with bronchiectasis in 1996 after the death of his wife. He struggled with fevers, infections, and just trying to get around. Although looking at him now at 80 years old, it is kind of hard to imagine that used to be the case.

Pulmonology
Blog

Improving the Management of Chronic Neurodegenerative Diseases with Interprofessional Collaboration & Care

Multiple sclerosis (MS) and Parkinson’s disease (PD) are 2 highly prevalent chronic progressive neurodegenerative disorders. Over time, the accumulation and subsequent worsening of the symptoms associated with these diseases can result in disability, impaired quality of life, loss of independence, and an increased burden on caregivers.

Neuroscience
Blog

Acute GvHD: Are You Avoiding These Common Treatment Pitfalls?

Allogenic hematopoietic stem cell transplantation (allo-HSCT) can be curative for many patients with hematologic malignancies. However, graft-versus-host disease (GvHD) remains one of the most common complications and one of the leading causes of death after unrelated HSCT. GvHD triples mortality rates.

Transplant
Blog

Refractory or Resistant Cytomegalovirus in Solid Organ Transplant Patients: Overcoming Challenges

Solid organ transplantation (SOT) revolutionized the treatment of organ failure and is a new lease on life for many patients. However, immunosuppressive medications used to prevent organ rejection increase the risk for infections, including cytomegalovirus (CMV). While many antiviral drugs are effective in treating CMV, refractory or resistant infections remain a constant threat.

Transplant
Blog

Emerging Therapies in Kidney Transplantation: What to Watch for in Chronic Active ABMR

Renal transplantation is a potentially life-saving treatment for those with renal failure; however, graft rejection remains a real problem and long-term outcomes remain poor. Although many renal transplants are performed worldwide each year, only a fraction are living with functioning renal grafts, with approximately 40% of renal transplants failing within 10 years.

Transplant
Blog

6 Ways to Help You Choose the Right Initial Therapy for Your Patient with Ulcerative Colitis

Choosing the correct first therapy for your patients with ulcerative colitis (UC) can be tricky, but it is important because it gives them the best chance at a better life with UC. Getting it right early increases their odds of remission and reduces their risk of progression, hospitalization, and colectomy. Here are 6 ways to help get it right the first time.

Gastroenterology
Blog

6 Ways to Personalize Your Patient’s Asthma Treatment Plan

Asthma management is increasingly becoming more personalized. Here are 6 ways you can help personalize treatment for your patients with asthma that is severe or difficult to control.

Allergy & Immunology, Pulmonology
Blog

Targeting BCMA: A New Path in Relapsed/Refractory Multiple Myeloma

In triple- and quad-refractory myeloma, median survival was only about 9 months, and less than 6 months in penta-refractory disease.

Hematology / Oncology
Blog

Navigating Immunotherapy in Advanced NSCLC: What Every Oncologist Should Know

The advent of immunotherapy has significantly extended survival and revolutionized care in advanced non-small cell lung cancer (NSCLC).

Hematology / Oncology
Blog

Is Immunotherapy Right for Your Patient with Nonmelanoma Skin Cancer?

The primary goal of treatment in nonmelanoma skin cancer (NMSC) is tumor elimination with maximal preservation of function and cosmesis.

Hematology / Oncology
Blog

These 3 Tools Will Change the Way You Manage IBD in Your Patients

Over the past couple of years, several clinical decision support tools (CDSTs) have emerged to more effectively risk stratify patients and one actually predicts their response to certain biologics before they even start them.

Gastroenterology
Blog

Try These Diets for Your Patients with EoE

In infancy, you can see feeding problems, and as the child progresses to adulthood, you will see them complain about vomiting, abdominal pain, difficulty swallowing, food impaction, and all of this may cause them to avoid eating certain foods, eat very slowly, or avoid social situations where food is involved.

Allergy & Immunology
Blog

New Treatments for SMA: Should We Offer Them to Adults?

Spinal muscular atrophy (SMA) is a genetic disorder and a devastating diagnosis for children and their families that can lead to death or a lifetime of severe disability and progressively limited mobility.

Neuroscience
Blog

Specialty Areas